Gordon Keith Wilcock
#123,191
Most Influential Person Now
Gordon Keith Wilcock's AcademicInfluence.com Rankings
Gordon Keith Wilcockbiology Degrees
Biology
#7595
World Rank
#10541
Historical Rank
Genetics
#732
World Rank
#824
Historical Rank
Molecular Biology
#884
World Rank
#907
Historical Rank
Download Badge
Biology
Gordon Keith Wilcock's Degrees
- PhD Genetics Stanford University
Why Is Gordon Keith Wilcock Influential?
(Suggest an Edit or Addition)Gordon Keith Wilcock's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
- The cholinergic hypothesis of Alzheimer’s disease: a review of progress (1999) (1688)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. (1985) (996)
- Plaques, tangles and dementia A quantitative study (1982) (609)
- Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (2000) (581)
- Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. (2009) (567)
- Herpes simplex virus type 1 in brain and risk of Alzheimer's disease (1997) (554)
- Alzheimer's disease Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities (1982) (538)
- Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. (1996) (511)
- Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination (1999) (477)
- Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease (1983) (429)
- Attentional control in Alzheimer's disease. (2001) (427)
- Association of interleukin‐1 gene polymorphisms with Alzheimer's disease (2000) (391)
- Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. (1985) (355)
- A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) (2002) (339)
- Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase (1983) (329)
- Neuropathological assessment of the lesions of significance in vascular dementia (1997) (319)
- Donepezil for the treatment of agitation in Alzheimer's disease. (2007) (276)
- Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease (1999) (267)
- The olfactory bulbs in Alzheimer's disease. (1984) (263)
- The metabolic syndrome and Alzheimer disease. (2007) (249)
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial (2016) (243)
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial (2008) (243)
- Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids (2000) (242)
- Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains (1991) (241)
- Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. (1999) (233)
- Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference. (2015) (215)
- Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. (2008) (213)
- Structural MRI changes detectable up to ten years before clinical Alzheimer's disease (2012) (213)
- A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease (2003) (200)
- Safety and efficacy of galantamine in subjects with mild cognitive impairment (2008) (197)
- Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease (1987) (188)
- alpha- and beta-secretase: profound changes in Alzheimer's disease. (2002) (178)
- Differential effects of the APOE genotype on brain function across the lifespan (2011) (178)
- Reporting standards for studies of diagnostic test accuracy in dementia (2014) (174)
- Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease? (2007) (173)
- Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients (2005) (159)
- Herpesviruses in brain and Alzheimer's disease (2002) (157)
- Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta‐analysis of individual patient data from randomised controlled trials (2004) (156)
- THE NUCLEUS BASALIS IN ALZHEIMER'S DISEASE: CELL COUNTS AND CORTICAL BIOCHEMISTRY (1983) (154)
- Cerebral amyloid angiopathy in dementia and old age. (1986) (154)
- Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration. (1998) (147)
- The prevalence, associations and symptoms of depression amongst dementia sufferers. (1996) (145)
- Endpoints for trials in Alzheimer's disease: a European task force consensus (2008) (143)
- Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy (2006) (142)
- Disease-modifying trials in Alzheimer's disease: a European task force consensus (2007) (142)
- Biomarkers for Alzheimer's disease therapeutic trials (2011) (138)
- Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type (1992) (137)
- Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force (2013) (137)
- Haplotypes extending across ACE are associated with Alzheimer's disease. (2003) (133)
- Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β‐amyloid metabolism (2004) (131)
- Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease (1998) (130)
- Hyperinsulinaemia and Alzheimer's disease. (1994) (128)
- Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. (1989) (123)
- Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function (2000) (120)
- Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. (2011) (113)
- Obesity, Abdominal Obesity and Alzheimer Disease (2006) (112)
- Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial (2017) (111)
- Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. (1999) (103)
- Differences in Cognitive Profile between TIA, Stroke and Elderly Memory Research Subjects: A Comparison of the MMSE and MoCA (2012) (98)
- Long‐term efficacy and safety of galantamine in patients with mild‐to‐moderate Alzheimer's disease: multicenter trial (2004) (93)
- Neuroanatomy of impaired self-awareness in Alzheimer's disease and mild cognitive impairment (2013) (91)
- Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease (1988) (90)
- PREVALENCE AND CORRELATES OF AGGRESSIVE BEHAVIOURS OCCURRING IN PATIENTS WITH ALZHEIMER'S DISEASE (1997) (90)
- APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. (2003) (89)
- Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease (2019) (89)
- Development of Screening Guidelines and Clinical Criteria for Predementia Alzheimer’s Disease (2008) (87)
- The second Leicester survey of memory clinics in the British Isles (2002) (86)
- The vitamin D receptor gene is associated with Alzheimer's disease (2011) (85)
- The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. (1988) (84)
- Premorbid effects of APOE on synaptic proteins in human temporal neocortex (2006) (82)
- Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype (1997) (80)
- α-2 macroglobulin polymorphism and Alzheimer disease risk in the UK (1999) (77)
- Dementia and Driving (1992) (75)
- Do Instrumental Activities of Daily Living Predict Dementia at 1‐ and 2‐Year Follow‐Up? Findings from the Development of Screening Guidelines and Diagnostic Criteria for Predementia Alzheimer's Disease Study (2011) (75)
- Evidence-based pharmacotherapy of Alzheimer's disease. (2004) (74)
- A One-Year Follow-Up Study of Depression in Dementia Sufferers (1996) (74)
- Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer’s disease and dementia (1998) (74)
- Cytomegalovirus Is Present in a Very High Proportion of Brains from Vascular Dementia Patients (2002) (72)
- Apolipoprotein E genotyping in Alzheimer's disease (1996) (72)
- Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls (1994) (71)
- Coping by the carers of dementia sufferers. (1995) (70)
- Benefits of total hip replacement to older patients and the community. (1978) (69)
- A follow up study of depression in the carers of dementia sufferers (1996) (69)
- The effects of galantamine treatment on caregiver time in Alzheimer's disease (2003) (69)
- Specific AD Impairment in Concurrent Performance of Two Memory Tasks (2007) (69)
- Abnormal visual search in mild cognitive impairment and Alzheimer’s disease (2005) (68)
- Associations of Psychotic Symptoms in Dementia Sufferers (1995) (68)
- Subjective Cognitive Decline (2015) (68)
- Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort. (2015) (67)
- Tumour necrosis factor-α gene polymorphisms and Alzheimer's disease (2003) (67)
- Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful (2003) (67)
- Memantine for the treatment of dementia (2003) (66)
- Predicting the time of conversion to MCI in the elderly (2009) (66)
- Enhancement of Antibody Responses to Influenza Vaccination in the Elderly following a Cognitive-Behavioural Stress Management Intervention (2003) (66)
- Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. (1984) (64)
- Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. (1987) (64)
- The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey (2015) (64)
- Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease (1993) (63)
- DECREASED CSF ACETYLCHOLINESTERASE ACTIVITY IN ALZHEIMER'S DISEASE (1983) (63)
- Classification of psychotic symptoms in dementia sufferers (1995) (61)
- The Increasing Burden of Alzheimer Disease (2003) (61)
- Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man (1998) (60)
- Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease (2005) (59)
- Lewy Body Dementia – Diagnosis and Treatment (1995) (59)
- Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex (2010) (59)
- Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project (2012) (58)
- Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer’s disease (2005) (58)
- Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease (2013) (58)
- The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project (2010) (58)
- Resting Functional Connectivity Reveals Residual Functional Activity in Alzheimer’s Disease (2013) (57)
- Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor (1997) (57)
- Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease (1989) (55)
- The prevalence of depression in the carers of dementia sufferers (1995) (55)
- Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease (2009) (54)
- Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay (2004) (54)
- Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. (1996) (54)
- Fortnightly Review: Vascular dementia (1996) (53)
- Contributors to white matter damage in the frontal lobe in Alzheimer's disease (2005) (53)
- Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain (2005) (52)
- A comparison of screening tools for the assessment of Mild Cognitive Impairment: Preliminary findings (2012) (52)
- APOE and cerebral amyloid angiopathy in the elderly (2003) (52)
- Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. (2012) (51)
- Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population (1998) (51)
- Visual mismatch negativity highlights abnormal pre-attentive visual processing in mild cognitive impairment and Alzheimer's disease (2008) (50)
- Blood Pressure, Dementia and Alzheimer’s Disease: The OPTIMA Longitudinal Study (2009) (49)
- Intra-individual reaction time variability in amnestic mild cognitive impairment: a precursor to dementia? (2012) (49)
- A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis (2014) (48)
- Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease (2006) (48)
- Distribution of β‐nerve growth factor receptors in the human basal forebrain (1989) (48)
- Cerebral Amyloid Angiopathy, Subcortical White Matter Disease and Dementia: Literature Review and Study in OPTIMA (2015) (48)
- Activation of caspase‐3 in permanent and transient brain ischaemia in man (2000) (46)
- Neurotropic viruses and Alzheimer's disease: a search for varicella zoster virus DNA by the polymerase chain reaction. (1997) (46)
- Cloning of a non-catalytic form of human trkBand distribution of messenger RNA for trkB in human brain (1994) (45)
- SEXUAL RELATIONSHIPS IN MARRIED DEMENTIA SUFFERERS (1997) (45)
- A discrete domain of the human TrkB receptor defines the binding sites for BDNF and NT-4. (2002) (45)
- A Prospective Study of Psychotic Symptoms in Dementia Sufferers: Psychosis in Dementia (1997) (45)
- Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study (2013) (44)
- Methodological issues in primary prevention trials for neurodegenerative dementia. (2009) (44)
- The sensitivity to change over time of the Bristol activities of daily living scale in Alzheimer's disease (2000) (44)
- Aberrant functional connectivity within the basal ganglia of patients with Parkinson's disease (2015) (44)
- An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease. (1993) (43)
- Cerebrovascular disease in dementia: the importance of atrial fibrillation. (1985) (42)
- Diagnosis and Management of Dementia: A Manual for Memory Disorders Teams (1999) (42)
- Presenilin-1 polymorphism and Alzheimer's disease (1996) (39)
- Identification and structure of the nerve growth factor binding site on TrkA. (2001) (39)
- New insights into feature and conjunction search: I. Evidence from pupil size, eye movements and ageing (2010) (39)
- ABCA7 p.G215S as potential protective factor for Alzheimer's disease (2016) (38)
- Galantamine in Alzheimer’s disease (2008) (37)
- Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer's disease brain using polymerase chain reaction. (1991) (37)
- Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease (2004) (37)
- The prevalence of osteoarthrosis of the hip requiring total hip replacement in the elderly. (1979) (37)
- Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post‐mortem diagnosis (2010) (36)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Living with mild cognitive impairment: the patient's and carer's experience (2012) (35)
- Cerebral Subcortical Small Vessel Disease in Subjects With Pathologically Confirmed Alzheimer Disease: A Clinicopathologic Study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) (2014) (35)
- Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain (1991) (35)
- Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis (2012) (34)
- The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project (2013) (34)
- APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. (2004) (33)
- TRAZODONE/TRYPTOPHAN FOR AGGRESSIVE BEHAVIOUR (1987) (33)
- Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease (1997) (32)
- Formal consensus and consultation: a qualitative method for development of a guideline for dementia. (1998) (32)
- An assessment of neurocognitive speed in relation to frailty. (2013) (31)
- Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease (2009) (31)
- Alzheimer's disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. (1995) (31)
- Failure to correlate C. pneumoniae with late onset Alzheimer's disease. (2002) (31)
- Mendelian adult-onset leukodystrophy genes in Alzheimer's disease: critical influence of CSF1R and NOTCH3 (2018) (31)
- Population-Based Case–Control Study of White Matter Changes on Brain Imaging in Transient Ischemic Attack and Ischemic Stroke (2013) (30)
- Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease (2013) (29)
- Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients. (2017) (29)
- PSYCHOTIC SYMPTOMS IN DEMENTIA AND THE RATE OF COGNITIVE DECLINE (1997) (29)
- Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease (2018) (28)
- Exploring the experiences of people with mild cognitive impairment and their caregivers with particular reference to healthcare – a qualitative study (2013) (28)
- Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis. (2019) (27)
- The −491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEϵ4 allele and Alzheimer's Disease (1999) (27)
- Clostridium difficile in acute and long-stay elderly patients. (1988) (27)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Visual search in mild cognitive impairment: a longitudinal study. (2011) (26)
- The aetiology of depression in the carers of dementia sufferers. (1995) (26)
- New insights into feature and conjunction search: II. Evidence from Alzheimer's disease (2010) (26)
- Rhabdomyolysis in elderly people after collapse. (1984) (25)
- Non-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study (2011) (24)
- Dementia and the Over-75 Check: the role of the primary care nurse. (2000) (24)
- APOE promoter, ACE1 and CYP46 polymorphisms and &bgr;-amyloid in Alzheimer's disease (2004) (24)
- Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease. (1984) (24)
- Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project. (2012) (23)
- Variability in scoring the Hachinski Ischaemic Score. (1995) (23)
- Ageing, cognition and dementia. (1997) (22)
- Determination of tacrine hydrochloride in human serum by chloroform extraction, reversed-phase high-performance liquid chromatography and fluorimetric detection. (1988) (22)
- Asymmetry of pathology in Alzheimer's disease. (1987) (22)
- Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus. (1991) (22)
- 578 Galanthamine hydrobromide — Interim results of a group comparative, placebo controlled, study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer's type (1996) (22)
- The Psychological Care of Medical Patients (1995) (22)
- Role of depression in predicting time to conversion to mild cognitive impairment. (2014) (21)
- Mini mental state examination (2000) (21)
- Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects (2011) (21)
- Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array (2017) (21)
- Placement of dementia sufferers in residential and nursing home care. (1998) (21)
- HSV-1 and risk of Alzheimer's disease (1998) (21)
- Premature white matter changes on brain imaging in relation to ischaemic stroke subtypes: population-based case-control study (2013) (21)
- The temporal lobe in dementia of Alzheimer's type. (1983) (21)
- Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project (2012) (19)
- Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid. (2014) (19)
- Exogenous phasic alerting and spatial orienting in mild cognitive impairment compared to healthy ageing: Study outcome is related to target response (2011) (19)
- Absence of Chlamydia pneumoniae in brain of vascular dementia patients (2003) (19)
- Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease (2006) (18)
- A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort. (2016) (18)
- Recombinant human nerve growth factor for clinical trials: protein expression, purification, stability and characterisation of binding to infusion pumps. (2001) (18)
- Progressive systemic sclerosis in the elderly. (1979) (18)
- Structural and functional bases of visuospatial associative memory in older adults (2013) (18)
- TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease (2009) (17)
- Alerting and orienting in Alzheimer's disease. (2006) (17)
- Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease (2016) (16)
- Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study (2016) (16)
- Clinical utility of computed tomography in the assessment of dementia: a memory clinic study (2004) (16)
- Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer’s disease (2007) (16)
- Economic aspects of the demand for total hip replacement in the elderly. (1979) (16)
- Patterns of Clinically Detectable Treatment Effects with Galantamine: A Qualitative Analysis (2002) (16)
- The development and validation of a patient-reported quality of life measure for people with mild cognitive impairment (2013) (16)
- Galantamine alleviates caregiver burden in Alzheimer's disease: A 6-month placebo-controlled study (2000) (15)
- Quantitative Morphometric Analysis of Basal Forebrain Neurons Expressing β-Nerve Growth Factor Receptors in Normal and Alzheimer's Disease Brains (1990) (15)
- Dementia: Molecules, Methods and Measures (1991) (15)
- Is there more to subjective cognitive impairment than meets the eye? A perspective. (2014) (14)
- Third IBRO World Congress of Neuroscience (1991) (14)
- Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease (2011) (14)
- No correlation between nigral degeneration and striatal plaques in Alzheimer’s disease (1996) (14)
- Long-term use of tacrine (1994) (14)
- Welcome to Alzheimer's Research & Therapy (2009) (13)
- Comparison of three silver stains for demonstrating neurofibrillary tangles and neuritic plaques in brain tissue stored for long periods (2004) (13)
- A placebo-controlled, double-blind trial of the selective AB-42 lowering agent, flurizan (MPC-7869, (R)-flurbiprofen) in patients with mild to moderate Alzheimer’s disease (2005) (13)
- Neuro-radiological findings and the magnitude of cognitive benefit by memantine treatment. A subgroup analysis of two placebo-controlled clinical trials in vascular dementia (2000) (13)
- Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer’s disease (2013) (12)
- What we have learned from the myriad trials (2009) (12)
- Side effects of benoxaprofen (1982) (12)
- Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month international multi-center phase 3 trial (2009) (12)
- A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease. (2019) (12)
- Disease-modifying treatments for Alzheimer’s disease: A perspective based on experience with R-Flurbiprofen (2006) (12)
- Bapineuzumab in Alzheimer's disease: where now? (2010) (12)
- Effect of vitamins and aspirin on markers of platelet activation oxidative stress and homocysteine in people at high risk of dementia (2003) (10)
- O4-03-08 Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, in Alzheimer’s disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study (2006) (9)
- A comparison of total hip replacement in patients aged 69 years or less and 70 years or over. (1981) (9)
- Use of a self-administered postal questionnaire when screening for health problems in the elderly. (1979) (9)
- Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease. (2001) (9)
- The association between APOE ε4 and Alzheimer-type dementia among memory clinic patients is confined to those with a higher education. The DESCRIPA Study. (2013) (9)
- Assessment Scales in Old Age Psychiatry, 2nd edition (2005) (9)
- CHOLINERGIC SIDE-EFFECTS OF TETRAHYDROAMINOACRIDINE (1988) (8)
- Use of whole blood for analysis of disease-associated biomarkers. (2013) (8)
- A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease. (2003) (7)
- P2-412 MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, delays time to clinically significant psychiatric events in Alzheimer’s disease (AD): Analysis from a 12-month phase 2 trial (2006) (7)
- Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT (2020) (7)
- Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias (2012) (7)
- DEPRESSION IN DEMENTIA SUFFERERS — COMPARISON OF DIAGNOSTIC CRITERIA (1997) (7)
- Galanthamine in Alzheimer’s Disease (1994) (6)
- British pharmacological society. (1967) (6)
- Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers? (1994) (6)
- The future of Age and Ageing. (2002) (6)
- Commentary ( The Renin Angiotensin System in Alzheimers Disease - Do Updates Highlight a Clinical and Biological Dichotomy? ) (2006) (5)
- AGE AND ALZHEIMER'S DISEASE (1983) (5)
- Age and Ageing – introducing our Associate Editors (2003) (5)
- A comparison of screening tools for the assessment of Mild Cognitive Impairment (2010) (5)
- Distribution of beta-nerve growth factor receptors in the human basal forebrain. (1989) (5)
- Meeting of Swiss Neuropathologists with International Participation (1981) (5)
- Interventions in Alzheimer's disease (2002) (4)
- Erratum to “TNFR-associated factor-2 (TRAF-2) in Alzheimer’s disease” [Culpan et al. (Neurobiol Aging 2009 July;30(7):1052-60)] (2010) (4)
- Recent research into dementia. (1988) (4)
- PHASE 3 TRIAL OF THE TAU AGGREGATION INHIBITOR LEUCO-METHYLTHIONINIUM-BIS (HYDROMETHANESULFONATE) (LMTM) IN MILD TO MODERATE ALZHEIMER'S DISEASE (2016) (3)
- Contents, Vol. 25, 1979 (1979) (3)
- Cholinesterase Inhibition for Alzheimer Disease (2016) (3)
- Galantamine in Alzheimer's (2008) (3)
- The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine (2007) (3)
- THE DEVELOPMENT AND VALIDATION OF A QUALITY OF LIFE MEASURE FOR PEOPLE WITH MILD COGNITIVE IMPAIRMENT (THE MCQ) (2013) (3)
- Is there more to subjective cognitive impairment than meets the eye? Raising awareness. (2014) (3)
- Prediction rules for computed tomography in the dementia assessment: do they predict clinical utility of CT? (2003) (3)
- Distribution and Characterization of β-Nerve Growth Factor Receptors in Alzheimer’s Disease (1991) (2)
- Treatment for Alzheimer's disease — where are we going? (2000) (2)
- Vitamin B12 Deficiency and Dementia (1992) (2)
- Brain tissue banks in psychiatric and neurological research. (1997) (2)
- A discrete domain of the human TrkB receptor defines the binding sites for brain-derived and neurotrophic factor and neurotrophin-4 (2002) (2)
- Exploring Time of Day Effects on Mini-Mental State Examination Performance in Alzheimer's Disease and Age-Associated Cognitive Decline (2005) (2)
- P3-203 TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease (2004) (2)
- Contribution Cognitive Lifestyle and Long-Term Risk of Dementia and Survival After Diagnosis in a Multicenter Population-based Cohort (2011) (2)
- Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease (1998) (2)
- Treatment for Alzheimer's disease (2000) (1)
- MMP-3 and -9 may degrade the perineuronal net but their activity is not increased in frontal cortex in Alzheimer's disease (2006) (1)
- Antidepressant medicines for the elderly: are we using them appropriately? (1994) (1)
- Neurofibrillary tangles interfere with transduction of TGF-beta signalling by neurons (2006) (1)
- Comparison of profiles of cognitive domain impairment on the MOCA and MMSE in an elderly versus a CVD population in a research setting (2011) (1)
- The absence of HLA-DRB1*03 is a risk factor in Alzheimer's disease (2001) (1)
- Vascular Risk Factors for Alzheimer's Disease: an Overview of Findings (2010) (1)
- Treatment of the cholinergic impairment in Alzheimer's disease (1994) (1)
- Alzheimer's Disease, Potential Therapeutic Strategies (1992) (1)
- Theolfactory bulbs inAlzheimer's disease (1984) (1)
- Cerebral amyloid angiopathy indementia andoldage (1986) (1)
- Editorial Welcome to Alzheimer's Research & Therapy (2009) (1)
- Assessment of the patient with apparent dementia (2010) (1)
- A SOCIAL HISTORY OF ENGLISH CHILDHOOD (2015) (1)
- Alzheimer's disease and insulin resistance (2004) (1)
- Bristol Activities of Daily Living Scale 1996 (2004) (1)
- Counselling for the carers. (1993) (1)
- Geriatric problems in general practice (1991) (1)
- The 9th international conference on Alzheimer's disease and related disorders. Philadelphia, USA (2004) (1)
- Alzheimer’s disease and related disorders annual 5 (2006) (1)
- Living with Alzheimer's disease and similar conditions : a guide families and carers (1999) (1)
- Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium. (1996) (1)
- Understanding health-care outcomes of older people with cognitive impairment and/or dementia admitted to hospital: a mixed-methods study (2021) (1)
- Criteria for assessing a client's fitness for admission to a welfare home: a practical proposition. (1982) (1)
- Corrigendum to “Visual mismatch negativity highlights abnormal pre-attentive visual processing in mild cognitive impairment and Alzheimer's disease” [Neuropsychologia 46 (5) (2008) 1224–1232] (2010) (1)
- N-acetyltransferase as a risk factor in neurodegenerative disease (2000) (0)
- A validation study of VCI genetics meta-analysis findings in a large collaborative cohort (2013) (0)
- P1-210 The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease (2004) (0)
- Primary prevention of dementia (2004) (0)
- Medicine in old age (2010) (0)
- The Authors Reply (2003) (0)
- Neurodegeneration and brain cancer: a longitudinal field study of rest-activity and sleep (2012) (0)
- Criteria forassessing aclient's fitness foradmission to awelfare home:apractical proposition (1982) (0)
- Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy (2006) (0)
- Chronic stress in humans is associated with altered lymphocyte proliferation (1998) (0)
- P3-103: Initial studies on the association between antemortem levels of cerebrospinal fluid β-secretase activity and post-mortem CERAD ratings of plaque densities in Alzheimer's disease (2008) (0)
- Assessment of dementia (2005) (0)
- Role of herpes viruses in Alzheimer's disease and of apolipoprotein E in other herpes virus diseases (2000) (0)
- Use of the mini‐mental state examination to determine the usefulness of subsequent cognitive assessment in moderately to severely demented subjects (1995) (0)
- Human Nerve growth factor receptor TrkA (2001) (0)
- Sharing the diagnosis in dementia: With whom and with what consequences? (2000) (0)
- Recent Alzheimer's disease research highlights (2012) (0)
- Alzheimer's disease: modernizing concept, biological diagnosis and therapy (2012) (0)
- atrial fibrillation . dementia : the importance of Cerebrovascular disease in (2008) (0)
- Structure of TrkAIg2 and molecular modelling of the neurotrophin binding sites of the Trk receptors (2000) (0)
- Putative genetic risk factors for Alzheimer's disease: assessment of association with parenchymal and vascular Aβ (2004) (0)
- Clinical Phonetics and Linguistics (1996) (0)
- Comparison of Beta-nerve growth factor content in normal and Alzheimer brain (1991) (0)
- Syntaxin 1A is a novel binding protein for Presenilin 1 (2000) (0)
- Living with Alzheimer's disease and similar conditions : the complete self-help guide for family and professional carers (1990) (0)
- Shaking the genome: new studies reveal genetic risk for Parkinson's disease (2010) (0)
- Neurotrophic Factors: Therapeutic Implications in Alzheimer's Disease (1992) (0)
- Neurofibrillary tangles interfere with the transduction of TGF-beta signaling in neurons (2006) (0)
- Contents, Vol. 40, 1994 (1994) (0)
- Original Article Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's dis- ease, observed by the Epistasis Project (2012) (0)
- DIFFERENTIAL DRIVING SKILLS IN DEMENTIA (1991) (0)
- Are Genetic Factors Relevant for the Aetiology of Leukoaraiosis (1998) (0)
- P3-056: An interactive frailty index predicts progression of cognitive impairment and mortality (2008) (0)
- Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. (1983) (0)
- An unfortunate case of allergy to latex (2000) (0)
- Care of the Elderly—The Way Ahead (1985) (0)
- 6th International Conference of Alzheimer's and Parkinson's disease. Seville (2001) (0)
- Subject Index Vol. 40, 1994 (1994) (0)
- Commentary for Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer’s Disease (2019) (0)
- Appendix: A survey of the Memory Disorder Teams represented by the (1999) (0)
- Industry Satellite Symposia (2007) (0)
- Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case control study (2011) (0)
- Neuronal ageing and its implications in human neurological pathology (Report of a WHO study group) (World Health Organization technical report series no. 665), 88 pages, World Health Organization, Geneva, 1981, Sfr 6.00 (1982) (0)
- 115th Meeting of the British Neuropathological Society Institute of Child Health, London (2014) (0)
- P4-142 Common variants of ACE contribute to variable age at onset of Alzheimer's disease (2004) (0)
- 12 Research potential (1999) (0)
- Correlates and Predictors of Psychological and Physical Morbidity in Chronic Caregiver Stress (1999) (0)
- A review of dementia. (1982) (0)
- P3-190: The retrospective application of the revised criteria for the diagnosis of Alzheimer's disease in subjects with autopsy diagnosis (2008) (0)
- Guideline for primary care management of dementia. Guideline should cover differential diagnosis. (1999) (0)
- Dementia: where has 2005 taken us? (2006) (0)
- Effect of Gender and Apolipoprotein E Genotype on Response to Anticholenesterase Therapy in Alzhelmer's Disease (1998) (0)
- Distribution of NGF Receptors in Control and Alzheimer’s Disease Basal Forebrain (1990) (0)
- Analysis of the major loop of presenilin 1 (1998) (0)
- dementia of Alzheimer ' s type . subcortical nuclei in senile The differential involvement of (0)
- Progressive systemic sclerosis intheelderly (1979) (0)
- Subject Index Vol. 30, 2008 (2008) (0)
- resting and task-related functional MRI in mild cognitive impairment and Alzheimer's disease (2011) (0)
- Changes to the Editorial Team (2004) (0)
- University of Birmingham Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease (2013) (0)
- Processing patterns during feature and conjunction in search in Alzheimer's disease: evidence from eye movements and pupil dilation (2007) (0)
- Cortical Aβ, cerebral amyloid angiopathy and white matter changes in Alzheimer's disease (2004) (0)
- Caveolin-1 does not influence cerebrovascular accumulation of Abeta in Alzheimer`s disease (2006) (0)
- Are life events a risk factor for Alzheimer's disease? (2010) (0)
- Senile Dementia of the Alzheimer type. Early diagnosis, neuropathology and animal models J. Traber and W. H. Gispen (eds). Springer-Verlag, Berlin (1985), 376 pp., DM138 (1986) (0)
- Self-appraisal in Alzheimer's disease, mild cognitive impairment and normal aging: An fMRI study (2010) (0)
- Evaluation of counselling services (1994) (0)
- The structural and functional neuroanatomy of successful visuospatial learning in normal aging (2010) (0)
- Aberrant functionalconnectivity withinthe basal ganglia of patients with Parkinson3 sd isease (2015) (0)
- Further characterisation of the major loop of Presenilin 1 (1998) (0)
- Neuropsychology and the dementias. By S. Hart and J. M. Semple. Taylor &s Francis, 1990. 343 + xi. ISBN 0–86377–196–3 (1992) (0)
- P3-162 Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology (2004) (0)
- Counselling for the carers (1993) (0)
- Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies (2002) (0)
- Using computerised lists of doctors (1981) (0)
- P4-102 Caveolin-1 does not influence cerebrovascular accumulation Aβ in Alzheimer’s disease (2006) (0)
- APOE-ε4 allele and neuropsychiatric symptoms in MCI: findings from the DESCRIPA study (2011) (0)
- The ageing brain and dementia. (1981) (0)
- Predicting progression to dementia in a memory clinic (2002) (0)
- Nerve Growth Factor and Other Biological Treatments: An Overview (1994) (0)
- Nerve growth factor and other neurotrophins in Alzheimer's disease (1994) (0)
- P4-097: Previous and concurrent blood pressure and cognitive function in dementia and Alzheimer's disease: The Oxford Project to Investigate Memory and Ageing (OPTIMA) Longitudinal Study (2008) (0)
- Secretase activity in Alzheimer's disease (2001) (0)
- Contents Vol. 30, 2008 (2008) (0)
- RESTING STATE FMRI DISCERNS EARLY PARKINSON'S FROM CONTROLS (2014) (0)
- RESTING FUNCTIONAL CONNECTIVITY REVEALS RESIDUAL FUNCTIONAL ACTIVITY IN ALZHEIMER'S DISEASE (2013) (0)
- Caregiver stress and disease vulnerability (2000) (0)
- Structural and functional magnetic resonance imaging (MRI) in the prediction and characterization of mild cognitive impairment (MCI) and Alzheimer's disease (AD) (2012) (0)
- P4-048: Pulse pressure, dementia and Alzheimer's disease: The Oxford Project to Investigate Memory and Ageing (OPTIMA) Longitudinal Study (2008) (0)
- A ROLE FOR PARP IN NECROSIS AFTER HUMAN BRAIN ISCHEMIA (1998) (0)
- The effects of ageing on processing load in feature and conjunction search: a pupil size and eye movement study (2005) (0)
- Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s disease (2013) (0)
- Neuropsychiatric symptoms associated with the APOE-ε4 allele in subjects with mild cognitive impairment in the DESCRIPA and ADNI cohorts (2012) (0)
- Cerebrospinal fluid amyloid oligomers measured in a subset of the aibl and optima age-matched healthy control and Alzheimer’s cohorts (2015) (0)
- Drug treatment of Alzheimer's disease — a clinician's view point (1991) (0)
- The Placing Test--Computerized Version (2020) (0)
- The clinical use of memantine. (2005) (0)
- How Many Assessments are Needed to Diagnose Dementia Accurately (1992) (0)
- NON-IMMUNOGLOBIN IN CEREBROSPINAL FLUID OF PATIENTS WITH ALZHEIMER'S DISEASE AND CEREBRAL AMYLOID ANGIOPATHY (1985) (0)
- Identification of the NGF binding site of the TrkA receptor (1998) (0)
- Introduction and Overview (1990) (0)
- 1HE7 - Human Nerve Growth Factor Receptor TrkA (2001) (0)
- Recent advances in epilepsy — 4. T. A. Pedley and B. S. Meldrum. Churchill Livingstone, Edinburgh, 1988. No. of pages: 266. Price: £45.00 (1989) (0)
- N-acetyltransferase (NAT2) genotype and susceptibility to AD, PD and DLB (2001) (0)
- Diagnostic Criteria for Vascular Dementia (1996) (0)
- NEURONAL DEATH IN HUMAN BRAIN INFARCTS (1999) (0)
- Irish gerontological society (1992) (0)
- APOE ε-associated reduction in presynaptic proteins in the superior temporal cortex in the under-70s (2004) (0)
- THE ROLE OF DEPRESSION IN PREDICTING THE TIME TO DEVELOPMENT OF MILD COGNITIVE IMPAIRMENT: A COHORT STUDY (2012) (0)
- Histaminergic H3 receptors in subcortical ischemic vascular dementia (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gordon Keith Wilcock?
Gordon Keith Wilcock is affiliated with the following schools:
